DISTRIBUTION AND METABOLISM IN HEALTHY-VOLUNTEERS OF DISODIUM AZODISALICYLATE, A POTENTIAL THERAPEUTIC AGENT FOR ULCERATIVE-COLITIS

被引:147
作者
WILLOUGHBY, CP
ARONSON, JK
AGBACK, H
BODIN, NO
TRUELOVE, SC
机构
[1] RADCLIFFE INFIRM,GASTROENTEROL UNIT,OXFORD OX2 6HE,ENGLAND
[2] RADCLIFFE INFIRM,MRC,CLIN PHARMACOL UNIT,OXFORD OX2 6HE,ENGLAND
[3] PHARMACIA AB,DEPT CHEM RES,UPPSALA,SWEDEN
[4] PHARMACIA AB,DEPT BIOL ANAL,UPPSALA,SWEDEN
关键词
D O I
10.1136/gut.23.12.1081
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1081 / 1087
页数:7
相关论文
共 14 条
[1]  
AZADKHAN AK, 1977, LANCET, V2, P892
[2]  
BARON JH, 1962, LANCET, V1, P1094
[3]   ADVERSE REACTIONS DURING SALICYLAZOSULFAPYRIDINE THERAPY AND RELATION WITH DRUG-METABOLISM AND ACETYLATOR PHENOTYPE [J].
DAS, KM ;
EASTWOOD, MA ;
MCMANUS, JPA ;
SIRCUS, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (10) :491-495
[4]   CONTROLLED TRIAL OF SULPHASALAZINE IN TREATMENT OF ULCERATIVE COLITIS [J].
DICK, AP ;
PETRIE, A ;
GRAYSON, MJ ;
CARPENTER, RG .
GUT, 1964, 5 (05) :437-&
[5]   CONTROLLED THERAPEUTIC TRIAL OF LONG-TERM MAINTENANCE TREATMENT OF ULCERATIVE-COLITIS WITH SULFASALAZINE (SALAZOPYRIN) [J].
DISSANAYAKE, AS ;
TRUELOVE, SC .
GUT, 1973, 14 (12) :923-926
[6]  
KHAN AKA, 1982, BRIT J CLIN PHARMACO, V13, P523
[7]  
KHAN AKA, 1980, GUT, V21, P232
[8]  
MISIEWICZ JJ, 1965, LANCET, V1, P185
[9]  
PEPPERCORN MA, 1973, GASTROENTEROLOGY, V64, P240
[10]  
SCHRODER H, 1972, CLIN PHARMACOL THER, V13, P539